Wojciech Biernat

Research interests

Publications

• Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)

  Journal of Thoracic Oncology · 2019 · 10.1016/j.jtho.2019.02.017

• Reactive astrocytic S1P3 signaling modulates the blood–tumor barrier in brain metastases

  Nature Communications · 2018 · 10.1038/s41467-018-05030-w

• Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

  Breast Cancer Research · 2016 · 10.1186/s13058-016-0702-8

• Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

  Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv161

• Sox10—A Marker for Not Only Schwannian and Melanocytic Neoplasms But Also Myoepithelial Cell Tumors of Soft Tissue

  The American Journal of Surgical Pathology · 2015 · https://doi.org/10.1097/pas.0000000000000398

• SALL4 Expression in Germ Cell and Non–Germ Cell Tumors

  The American Journal of Surgical Pathology · 2014 · 10.1097/pas.0000000000000116

• Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement

  Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2014 · 10.1007/s00428-014-1701-8

• GATA3

  The American Journal of Surgical Pathology · 2013 · https://doi.org/10.1097/pas.0b013e3182a0218f

• Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer

  British Journal of Cancer · 2012 · 10.1038/bjc.2012.335

• Predominant Expression of Mutant EGFR (EGFRvIII) is Rare in Primary Glioblastomas

  Brain Pathology · 2004 · 10.1111/j.1750-3639.2004.tb00045.x

• Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis

  International Journal of Cancer · 2003 · 10.1002/ijc.11254

• PTEN (MMAC1) Mutations Are Frequent in Primary Glioblastomas (de novo) but not in Secondary Glioblastomas

  Journal of Neuropathology & Experimental Neurology · 1998 · https://doi.org/10.1097/00005072-199807000-00005

• Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas

  Acta Neuropathologica · 1997 · 10.1007/s004010050711

• Amplification and Overexpression of MDM2 in Primary (de novo) Glioblastomas

  Journal of Neuropathology & Experimental Neurology · 1997 · 10.1097/00005072-199702000-00009

• Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.

  PubMed · 1997

• Identical Mutations of the p53 Tumor Suppressor Gene in the Gliomatous and the Sarcomatous Components of Gliosarcomas Suggest a Common Origin from Glial Cells

  Journal of Neuropathology & Experimental Neurology · 1995 · 10.1097/00005072-199509000-00006

Current projects

No projects listed.